Likewise, rapamycin treatment during crucial stages of infection impaired glycolysis and impeded CD8+ effector function and pathogen clearance during infection with lymphocytic choriomeningitis virus (LCMV) and L. monocytogenes (59). This evidence concerns the gene CD8A and infection.